Congratulations to Jan Teller, DMRF’s Chief Scientific
Officer on his recognition from the Drug Information Association (DIA) as a
Patient Advocate Fellow. Dr. Teller will
represent the DMRF at the upcoming DIA annual meeting in Boston, MA. He is one of 19 representatives selected from
patient organizations working on rare or underrepresented diseases.
While at this national meeting, Dr. Teller will meet on drug
discovery, management of pharmaceuticals, biotech, medical devices and other
clinical applications. Fellows will also be given a unique opportunity to meet
with policymakers, industry representatives, and research institutions. It is good to know dystonia will be
represented so well at this important meeting.
Many thanks to Dr. Teller for his efforts here and with all he does for
the dystonia community. Way to go!!
Dr. Teller (left) works closely with DMRF Scientific Director
Mahlon R. DeLong, MD, Professor of Neurology, The Emory Clinic, on all aspects of the DMRF Science Program.
No comments:
Post a Comment